Tag Archives: Kevin Conroy

Exact Sciences logo

Exact Sciences Acquires Two Companies

Exact Sciences has acquired Paradigm Diagnostics and Viomics to extend its lab testing and research and development capabilities, the company announced recently. According to a release, Paradigm offers a comprehensive…

Cologuard Garners Another FDA Approval

The U.S. Food and Drug Administration approved Exact Sciences‘ Cologuard for use by eligible average-risk individuals ages 45 and older, the company announced today. Previously, the FDA had approved use…

Exact Sciences logo

Exact Sciences to Acquire Genomic Health

Exact Sciences will acquire Genomic Health, a provider of genomic-based diagnostic tests that help optimize cancer care, in a cash and stock transaction valued at $2.8 billion, the company announced today. According to…

Exact Sciences logo

Exact Sciences Opens New Lab

Exact Sciences opened its new 169,000-square foot clinical lab on the west side of Madison this week, the company announced recently. “Madison, Wisconsin is the home of earlier cancer detection,”…

Exact Sciences logo

Exact Sciences, Mayo Clinic Report Initial Results

Exact Sciences, along with the Mayo Clinic, reports that early research using blood-based methylated DNA markers demonstrate a potential to achieve 92% sensitivity and 92% specificity for detecting the most…

Exact Sciences logo

Former HHS Secretary Joins Exact Sciences Board

Exact Sciences announced today that former U.S. Department of Health and Human Services Secretary Kathleen Sebelius has joined its board of directors. “Secretary Sebelius understands the value of detecting cancer earlier, as…

Exact Sciences’ Cologuard Helps Two Million

More than two million Americans have been screened for colorectal cancer using Exact Sciences‘ Cologuard, the company announced today. “Cologuard is changing how Americans get screened for colorectal cancer and,…

Exact Sciences logo

Exact Sciences Releases 2018 Report

Exact Sciences recently announced its latest financial report, which showed revenue of $454.5 million and  934,000 completed Cologuard tests during last year, an increase of 71 percent and 64 percent, respectively,…

Exact Sciences logo

Exact Sciences Releases Q4 Stats

Exact Sciences recently announced its fourth quarter numbers, which included revenues between $142.5 million – $143.5 million and 292,000 completed Cologuard tests, an increase of 64 percent and 66 percent…

Exact Sciences logo

Exact Sciences Sees Growth in Tests

Exact Sciences recently announced its third quarter numbers, which included revenue of $118.3 million and 240,000 completed Cologuard tests, an increase of 63 percent and 49 percent, respectively. “The Exact…